Current
0.46 €
Start price
1.18 €
Target price
–
End price
0.78 €
Performance (%)
-34.12%
Confidence
0%
Time horizon
2023-06-28
Performance since start
How it ranks
- #33 Rank 33 of 47 by performance
- 32 ratings for this instrument performed better
- No other running rating for this instrument right now
Summary
This prediction ended on 29.06.22 with a price of €0.78. me8 correctly predicted massive losses of -34.12% for Evofem Biosciences Inc.. This prediction was marked as speculative and is excluded from me8's performance statistics.
Investment thesis
Pros and cons by me8
For
Good culture
Against
Risky Investment
No Innovation
Timeline & discussion
Reasoning and updates for this rating
The discussion is visible to sharewise members.
2 comments are waiting for you.